SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 517 filers reported holding SEAGEN INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,523,545 | -3.1% | 186,300 | -12.1% | 0.17% | -2.2% |
| Q2 2023 | $40,782,274 | +760.6% | 211,900 | +511.9% | 0.18% | +673.9% |
| Q3 2022 | $4,739,000 | +1009.8% | 34,632 | +1334.6% | 0.02% | +1050.0% |
| Q2 2022 | $427,000 | +15.4% | 2,414 | -5.9% | 0.00% | +100.0% |
| Q1 2022 | $370,000 | +1380.0% | 2,566 | +1484.0% | 0.00% | – |
| Q4 2021 | $25,000 | -10.7% | 162 | 0.0% | 0.00% | – |
| Q3 2021 | $28,000 | +7.7% | 162 | 0.0% | 0.00% | – |
| Q2 2021 | $26,000 | -71.4% | 162 | -75.3% | 0.00% | – |
| Q1 2021 | $91,000 | -22.2% | 657 | -1.5% | 0.00% | – |
| Q4 2020 | $117,000 | – | 667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 47,288,259 | $7,465,870,000 | 32.79% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 145,000 | $22,868,000 | 6.04% |
| Lagoda Investment Management, L.P. | 59,780 | $9,438,000 | 4.40% |
| Avidity Partners Management LP | 640,000 | $101,043,000 | 2.73% |
| PFM Health Sciences, LP | 482,985 | $76,254,000 | 2.39% |
| Boxer Capital, LLC | 400,000 | $63,152,000 | 2.23% |
| Redmile Group, LLC | 771,385 | $121,786,000 | 1.80% |
| Woodline Partners LP | 577,655 | $91,200,000 | 1.70% |
| Rhenman & Partners Asset Management AB | 157,925 | $24,933,000 | 1.69% |
| Parkman Healthcare Partners LLC | 45,176 | $7,132,000 | 1.56% |